Severe Asthma Management

Publication Date: October 1, 2019

Key Points

Key Points

Following the recent appearance of new anti-interleukin biologic agents and standardization of sputum eosinophil counts and exhaled nitric oxide fraction (FENO), ATS/ERS have added recommendations for these agents for adults with severe uncontrolled asthma and modified certain other recommendations from the 2014 guideline.

Treatment

Treatme...

...mendations for the Management of Severe Asth...

...st an anti-IL-5 strategy as add-on therapy for adu...

...suggest that a blood eosinophil cut-po...

...ggest using a blood eosinophil cut...

...using a FENO cut-off ≥19.5 ppb to...

...ldren, adolescents and adults with se...

We suggest a trial of macrolide treatment...

...nst the use of chronic macrolide treatment in chi...

...t dupilumab as add-on therapy for adult...


...oclonal Antibodies for Severe AsthmaHaving t...